2019
DOI: 10.1016/j.scib.2019.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic supraparticles for the treatment of age-related diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 156 publications
(175 reference statements)
0
2
0
Order By: Relevance
“…1d and Supplementary Fig. 4) [32][33][34] . In contrast, the control NP 1 nanoparticles with no end groups failed to form coacervates via fluid-fluid phase separation, thereby confirming the importance of the physical interactions of end groups to the formation of NPA coacervates (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 97%
“…1d and Supplementary Fig. 4) [32][33][34] . In contrast, the control NP 1 nanoparticles with no end groups failed to form coacervates via fluid-fluid phase separation, thereby confirming the importance of the physical interactions of end groups to the formation of NPA coacervates (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 97%
“…Biocompatibility is another essential consideration for photonic nanomedicines in biomedical applications [64][65][66]. Therefore, we assessed the hemolysis and cytotoxicity of SnNSs@PEG.…”
Section: Biocompatibility Of Snnss@pegmentioning
confidence: 99%